Cargando…
Vitamin D3 potentiates the antitumorigenic effects of arsenic trioxide in human leukemia (HL-60) cells
BACKGROUND: Arsenic trioxide (ATO) is a novel form of therapy that has been found to aid acute promyelocytic leukemia (APL) patients. Our laboratory has demonstrated that ATO-induced cytotoxicity in human leukemia (HL-60) cells is mediated by oxidative stress. Pro-oxidants have been known to play a...
Autores principales: | Rogers, Christian S, Yedjou, Clement G, Sutton, Dwayne J, Tchounwou, Paul B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973008/ https://www.ncbi.nlm.nih.gov/pubmed/24661615 http://dx.doi.org/10.1186/2162-3619-3-9 |
Ejemplares similares
-
Dose- and Time-Dependent Response of Human Leukemia (HL-60) Cells to Arsenic Trioxide Treatment
por: Yedjou, Clement G., et al.
Publicado: (2006) -
Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells
por: Yedjou, Clement, et al.
Publicado: (2010) -
Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells
por: Kumar, Sanjay, et al.
Publicado: (2014) -
Ascorbic Acid Potentiation of Arsenic Trioxide Anticancer Activity Against Acute Promyelocytic Leukemia
por: Yedjou, Clement, et al.
Publicado: (2009) -
Basic Apoptotic Mechanisms of Lead Toxicity in Human Leukemia (Hl-60) Cells
por: Yedjou, Clement G., et al.
Publicado: (2010)